AUKEN WENDELL G VAN III

CIK 00011971103 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001197110

Recent Transactions

50 trades

Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30+1,166,695→ 1,166,695 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series B Preferred Stock
2005-09-30−1,096,153→ 0 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30$7.00/sh+66,500→ 1,233,195 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30+1,166,695→ 1,166,695 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30+61,405→ 61,405 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series B Preferred Stock
2005-09-30−57,693→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series C Preferred Stock
2005-09-30−593,750→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2005-09-30−155,000→ 0 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30$7.00/sh+3,500→ 64,905 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2005-09-30−2,945,000→ 0 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30$7.00/sh+3,500→ 64,905 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30$7.00/sh+66,500→ 1,233,195 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series C Preferred Stock
2005-09-30−31,250→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series B Preferred Stock
2005-09-30−1,096,153→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series B Preferred Stock
2005-09-30−57,693→ 0 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30$7.00/sh+66,500→ 1,233,195 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series C Preferred Stock
2005-09-30−593,750→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30+61,405→ 61,405 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series C Preferred Stock
2005-09-30−31,250→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2005-09-30−155,000→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series B Preferred Stock
2005-09-30−57,693→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30+1,166,695→ 1,166,695 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2005-09-30−2,945,000→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2005-09-30−2,945,000→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series C Preferred Stock
2005-09-30−593,750→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2005-09-30−155,000→ 0 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30$7.00/sh+66,500→ 1,233,195 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series C Preferred Stock
2005-09-30−593,750→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series C Preferred Stock
2005-09-30−31,250→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30+1,166,695→ 1,166,695 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30$7.00/sh+3,500→ 64,905 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series B Preferred Stock
2005-09-30−1,096,153→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30+1,166,695→ 1,166,695 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30+61,405→ 61,405 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30$7.00/sh+3,500→ 64,905 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series B Preferred Stock
2005-09-30−1,096,153→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30+61,405→ 61,405 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2005-09-30−2,945,000→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series C Preferred Stock
2005-09-30−31,250→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2005-09-30−155,000→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series B Preferred Stock
2005-09-30−57,693→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30+61,405→ 61,405 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2005-09-30−2,945,000→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2005-09-30−155,000→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series B Preferred Stock
2005-09-30−57,693→ 0 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30$7.00/sh+3,500→ 64,905 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series B Preferred Stock
2005-09-30−1,096,153→ 0 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2005-09-30$7.00/sh+66,500→ 1,233,195 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series C Preferred Stock
2005-09-30−31,250→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series C Preferred Stock
2005-09-30−593,750→ 0 total

Companies

Recent Filings

4
SUNESIS PHARMACEUTICALS INC
Oct 4, 2005

Address

2800 SAND HILL ROAD SUITE 250

MENLO PARK, CA, 94025

View on SEC.gov